ASPG and acute lymphoblastic leukemia: Background Asparaginase (ASP) is a key component of pediatric acute lymphoblastic leukemia (ALL) therapy, but its use is limited by concerns about hypersensitivity, hepatic dysfunction, pancreatitis, thrombosis, and other toxicities.